Editorial introductions

Abstract

Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Megan R. HaymartMegan R. HaymartMegan R. Haymart, MD, is the Nancy Wigginton Endocrinology Research Professor in Thyroid Cancer and Professor of Medicine at the University of Michigan. Dr Haymart received her medical degree from Johns Hopkins University School of Medicine in 2002, completed internal medicine residency at Johns Hopkins Hospital in 2005, and then completed fellowship in endocrinology, diabetes and metabolism at the University of Wisconsin in 2007. Dr Haymart is involved in creating the National Comprehensive Cancer Network thyroid carcinoma guidelines and the upcoming American Thyroid Association adult differentiated thyroid cancer guidelines. She serves on the editorial board for the Journal of Clinical Oncology and Journal of Clinical Endocrinology and Metabolism, and as Associate Editor for Thyroid. She has previously served on the Board of Directors for the American Thyroid Association, as Clinical Science Chair for the Endocrine Society Annual Meeting Steering Committee, and as President of Women in Thyroidology. Dr Haymart has a history of NIH-funded research focused on optimizing cancer care delivery and understanding and addressing thyroid cancer overdiagnosis and overtreatment. Maria PapaleontiouMaria PapaleontiouMaria Papaleontiou, MD, is an Assistant Professor of Internal Medicine in the Division of Metabolism, Endocrinology and Diabetes and a Research Assistant Professor in the Institute of Gerontology at the University of Michigan. Dr Papaleontiou's clinical practice focuses on geriatric endocrinology and thyroidology. She also conducts health services research in the field of thyroidology and aging, and has received funding from the National Institute on Aging, the Claude D. Pepper Center, the Elizabeth Caroline Crosby Research Fund, and the University of Michigan Biology of Cardiovascular Aging Core, among others. She is a nationally recognized expert in thyroid disease with a repertoire of more than 50 peer-reviewed publications in the field. She has had leadership positions in multiple national societies, including Clinical Science Chair of the Annual Program Committee at the American Thyroid Association (ATA), Chair for ATA's Women in Thyroidology, Vice-Chair for the American Association of Clinical Endocrinology's Thyroid Disease State Network and Chair for the Ethics Committee for the North American Society for Interventional Thyroidology. She also serves as Co-Chair for the revised ATA Hypothyroidism Guidelines. She is an Associate Editor for Endocrine Practice and Hormones, and on the editorial boards for Thyroid and BMC Endocrine Disorders